Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 May 1;25(9):1846–1853. doi: 10.1093/nar/25.9.1846

Effects of hypoxanthine substitution on bleomycin-mediated DNA strand degradation in DNA-RNA hybrids.

M Bansal 1, J Stubbe 1, J W Kozarich 1
PMCID: PMC146653  PMID: 9108170

Abstract

We have reported on the differences in site-specific cleavage between DNA and DNA-RNA hybrids by various prototypic DNA cleavers (accompanying paper). In the case of bleomycin (BLM), degradation at 5'-GC-3'sites was suppressed relative to the same sequence in double-stranded DNA, while 5'-GT-3' damage remained constant. We now present results of our further investigation on the chemical and conformational factors that contribute to BLM-mediated DNA strand cleavage of DNA-RNA hybrids. Substitution of guanine by hypoxanthine on the RNA strand of hybrids resulted in a significant enhancement of 5'-GC-3' site damage on the DNA strand relative to double-stranded DNA, thus reversing the suppression noted at these sites. Additionally, 5'-AT-3' sites, which are damaged significantly more in the hybrid than in DNA, exhibit decreased product formation when hypoxanthine is present on the RNA strand of hybrids. However, when hypoxanthine is substituted for guanine on the DNA strand (a GC cleavage site becomes IC), 5'-IT-3' and 5'-IC-3' site cleavage is almost completely suppressed, whereas AT site cleavage is dramatically enhanced. The priority in metallobleomycin site-specific cleavage of hybrids changes with hypoxanthine substitution: the cleavage priority is AT > GT > GC in native hybrid; GC > GT > AT in hybrids substituted with hypoxanthine in the RNA strand; AT >> GT approximately GC in hybrids substituted with hypoxanthine in the DNA strand. The results of kinetic isotope effect studies on BLM cleavage are presented and, in most cases, the values are larger for the hypoxanthine-substituted hybrid. The results suggest that the 2-amino groups of guanine residues on both strands of the nucleic acid play an important role in modulation of the binding and cleavage specificity of BLM.

Full Text

The Full Text of this article is available as a PDF (157.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Absalon M. J., Krishnamoorthy C. R., McGall G., Kozarich J. W., Stubbe J. Bleomycin mediated degradation of DNA-RNA hybrids does not involve C-1' chemistry. Nucleic Acids Res. 1992 Aug 25;20(16):4179–4185. doi: 10.1093/nar/20.16.4179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ajmera S., Wu J. C., Worth L., Jr, Rabow L. E., Stubbe J., Kozarich J. W. DNA degradation by bleomycin: evidence for 2'R-proton abstraction and for C-O bond cleavage accompanying base propenal formation. Biochemistry. 1986 Oct 21;25(21):6586–6592. doi: 10.1021/bi00369a037. [DOI] [PubMed] [Google Scholar]
  3. Arnott S., Chandrasekaran R., Millane R. P., Park H. S. DNA-RNA hybrid secondary structures. J Mol Biol. 1986 Apr 20;188(4):631–640. doi: 10.1016/s0022-2836(86)80011-0. [DOI] [PubMed] [Google Scholar]
  4. Bansal M., Lee J. S., Stubbe J., Kozarich J. W. Mechanistic analyses of site-specific degradation in DNA-RNA hybrids by prototypic DNA cleavers. Nucleic Acids Res. 1997 May 1;25(9):1836–1845. doi: 10.1093/nar/25.9.1836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carter B. J., de Vroom E., Long E. C., van der Marel G. A., van Boom J. H., Hecht S. M. Site-specific cleavage of RNA by Fe(II).bleomycin. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9373–9377. doi: 10.1073/pnas.87.23.9373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chou S. H., Flynn P., Reid B. High-resolution NMR study of a synthetic DNA-RNA hybrid dodecamer containing the consensus pribnow promoter sequence: d(CGTTATAATGCG).r(CGCAUUAUAACG). Biochemistry. 1989 Mar 21;28(6):2435–2443. doi: 10.1021/bi00432a014. [DOI] [PubMed] [Google Scholar]
  7. D'Andrea A. D., Haseltine W. A. Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3608–3612. doi: 10.1073/pnas.75.8.3608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dasgupta D., Goldberg I. H. Mode of reversible binding of neocarzinostatin chromophore to DNA: base sequence dependency of binding. Nucleic Acids Res. 1986 Jan 24;14(2):1089–1105. doi: 10.1093/nar/14.2.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ishii S., Merlino G. T., Pastan I. Promoter region of the human Harvey ras proto-oncogene: similarity to the EGF receptor proto-oncogene promoter. Science. 1985 Dec 20;230(4732):1378–1381. doi: 10.1126/science.2999983. [DOI] [PubMed] [Google Scholar]
  10. Kuwahara J., Sugiura Y. Sequence-specific recognition and cleavage of DNA by metallobleomycin: minor groove binding and possible interaction mode. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2459–2463. doi: 10.1073/pnas.85.8.2459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Magliozzo R. S., Peisach J., Ciriolo M. R. Transfer RNA is cleaved by activated bleomycin. Mol Pharmacol. 1989 Apr;35(4):428–432. [PubMed] [Google Scholar]
  12. Maxam A. M., Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 1980;65(1):499–560. doi: 10.1016/s0076-6879(80)65059-9. [DOI] [PubMed] [Google Scholar]
  13. Milligan J. F., Uhlenbeck O. C. Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 1989;180:51–62. doi: 10.1016/0076-6879(89)80091-6. [DOI] [PubMed] [Google Scholar]
  14. Oakley J. L., Strothkamp R. E., Sarris A. H., Coleman J. E. T7 RNA polymerase: promoter structure and polymerase binding. Biochemistry. 1979 Feb 6;18(3):528–537. doi: 10.1021/bi00570a023. [DOI] [PubMed] [Google Scholar]
  15. Salazar M., Fedoroff O. Y., Miller J. M., Ribeiro N. S., Reid B. R. The DNA strand in DNA.RNA hybrid duplexes is neither B-form nor A-form in solution. Biochemistry. 1993 Apr 27;32(16):4207–4215. doi: 10.1021/bi00067a007. [DOI] [PubMed] [Google Scholar]
  16. Takeshita M., Grollman A. P., Ohtsubo E., Ohtsubo H. Interaction of bleomycin with DNA. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5983–5987. doi: 10.1073/pnas.75.12.5983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Umezawa H., Maeda K., Takeuchi T., Okami Y. New antibiotics, bleomycin A and B. J Antibiot (Tokyo) 1966 Sep;19(5):200–209. [PubMed] [Google Scholar]
  18. Worth L., Jr, Frank B. L., Christner D. F., Absalon M. J., Stubbe J., Kozarich J. W. Isotope effects on the cleavage of DNA by bleomycin: mechanism and modulation. Biochemistry. 1993 Mar 16;32(10):2601–2609. doi: 10.1021/bi00061a018. [DOI] [PubMed] [Google Scholar]
  19. Wu J. C., Kozarich J. W., Stubbe J. Mechanism of bleomycin: evidence for a rate-determining 4'-hydrogen abstraction from poly(dA-dU) associated with the formation of both free base and base propenal. Biochemistry. 1985 Dec 17;24(26):7562–7568. doi: 10.1021/bi00347a009. [DOI] [PubMed] [Google Scholar]
  20. Wu J. C., Kozarich J. W., Stubbe J. The mechanism of free base formation from DNA by bleomycin. A proposal based on site specific tritium release from Poly(dA.dU). J Biol Chem. 1983 Apr 25;258(8):4694–4697. [PubMed] [Google Scholar]
  21. Wu J. C., Stubbe J., Kozarich J. W. Mechanism of bleomycin: evidence for 4'-ketone formation in poly(dA-dU) associated exclusively with free base release. Biochemistry. 1985 Dec 17;24(26):7569–7573. doi: 10.1021/bi00347a010. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES